• Created on the 26 May, 2017.


Human AMA-M2 ELISA kit is designed for detecting in vitro quantitative concentrations of IgG autoantibodies against mitochondrial M2 subtype antigen (AMA-M2) in human plasma and serum samples. This assay has a minimum analytical sensitivity limit of 1.0 IU/ml.


Anti-mitochondrial antibodies (AMA) are made up immunoglobulins that are formed against mitochondria which are primarily located in cells of the liver. These have been associated to a number of different conditions such as anti M2, M4, M8 and M9 are predominately linked to biliary cirrhosis, M1 to syphilis, M2 to autoimmune hepatitis, M3 to drug-induced lupus erythematosus, M6 to drug-induced hepatitis, M7 to myocarditis and cardiomyopathy and M5 to undifferentiated collagenosis, systemic lupus erythematosus and autoimmune haemolytic anaemia. Anti-mitochondrial antibodies have also been identified in systemic sclerosis, Sjögren’s syndrome, asymptomatic recurrent bacteriuria and pulmonary tuberculosis.

The presence of AMA in serum or blood can indicate the potential of developing primary biliary cholangitis (PBC). PBC has been found in causes of scarring to liver tissue and AMA is also found in more than 95% of these cases. AMA-M2 ELISA kit is recommended for the differential diagnosis of PBC, since it is highly sensitive and specific. Beginning cases of symptomatic PBC usually display only AMA-M2 subtype antibodies, whereas progressive cases and mixed syndromes are linked with AMA-M2, -M4 and -M8 antibody subtypes. Therefore, profiling the AMA subtypes can allow the determination of an immunological and prognostic classification of the primary biliary cirrhosis.


The minimum detection sensitivity level of IgG autoantibodies against mitochondrial M2 using current human AMA-M2 ELISA kit was 1.0 IU/ml. The dynamic range for this assay is 12.5 – 200.0 IU/ml.


  1. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis. Clin Chim Acta. (2017) 464: 113-117. Han E., et al.
  2. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int. (2004) 3 (2): 288-91. Zhang F.K., et al.
  3. Detection of AMA-M2 in human saliva: Potentials in diagnosis and monitoring of primary biliary cholangitis. Sci Rep. (2017) 7 (1): 796. Lu C., et al.
  4. The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis. Clin Chem Lab Med. (2014) 52 (11): 1533-42. Review. Hu S., et al.


  • Full Name: AMA-M2 ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum, Plasma
  • Sensitivity: 1.0 IU/ml



Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford